117 related articles for article (PubMed ID: 35932099)
21. Survival outcomes in patients with multiple primary melanomas.
Rowe CJ; Law MH; Palmer JM; MacGregor S; Hayward NK; Khosrotehrani K
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2120-7. PubMed ID: 25864459
[TBL] [Abstract][Full Text] [Related]
22. Risk of subsequent cutaneous squamous cell carcinoma in patients with melanoma.
Asgari MM; Warton EM; Quesenberry CP; Koralek DO; Taylor M
J Am Acad Dermatol; 2014 Sep; 71(3):521-8. PubMed ID: 24856040
[TBL] [Abstract][Full Text] [Related]
23. Comparison of phenotypic features in patients with single vs multiple primary cutaneous melanomas: a prospective single-center study.
Farabi B; Bostanci S; Akay BN; Caliskan D; Atak MF
Int J Dermatol; 2023 Jan; 62(1):66-72. PubMed ID: 36254676
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study.
Espinosa P; Pfeiffer RM; García-Casado Z; Requena C; Landi MT; Kumar R; Nagore E
Eur J Cancer; 2016 Jan; 53():115-24. PubMed ID: 26702765
[TBL] [Abstract][Full Text] [Related]
25. Multiple primary melanomas: do they look the same?
Moscarella E; Rabinovitz H; Puig S; Zalaudek I; Oliviero MC; Brown L; Alarcon I; Malvehy J; Longo C; Formisano D; Carrera C; Badenas C; Piana S; Albertini G; Pellacani G; Argenziano G
Br J Dermatol; 2013 Jun; 168(6):1267-72. PubMed ID: 23374221
[TBL] [Abstract][Full Text] [Related]
26. Clinical Features and Survival of Multiple Primary Melanoma: A Belgian Single Center Cohort.
Absil G; Collins P; Seidel L; Damsin T; Nikkels AF
Dermatol Ther (Heidelb); 2023 Feb; 13(2):641-649. PubMed ID: 36609959
[TBL] [Abstract][Full Text] [Related]
27. Role of the CDKN2A locus in patients with multiple primary melanomas.
Puig S; Malvehy J; Badenas C; Ruiz A; Jimenez D; Cuellar F; Azon A; Gonzàlez U; Castel T; Campoy A; Herrero J; Martí R; Brunet-Vidal J; Milà M
J Clin Oncol; 2005 May; 23(13):3043-51. PubMed ID: 15860862
[TBL] [Abstract][Full Text] [Related]
28. Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.
Bruno W; Pastorino L; Ghiorzo P; Andreotti V; Martinuzzi C; Menin C; Elefanti L; Stagni C; Vecchiato A; Rodolfo M; Maurichi A; Manoukian S; De Giorgi V; Savarese I; Gensini F; Borgognoni L; Testori A; Spadola G; Mandalà M; Imberti G; Savoia P; Astrua C; Ronco AM; Farnetti A; Tibiletti MG; Lombardo M; Palmieri G; Ayala F; Ascierto P; Ghigliotti G; Muggianu M; Spagnolo F; Picasso V; Tanda ET; Queirolo P; Bianchi-Scarrà G
J Am Acad Dermatol; 2016 Feb; 74(2):325-32. PubMed ID: 26775776
[TBL] [Abstract][Full Text] [Related]
29. Risk Factors of Subsequent Primary Melanomas in Austria.
Müller C; Wendt J; Rauscher S; Sunder-Plassmann R; Richtig E; Fae I; Fischer G; Okamoto I
JAMA Dermatol; 2019 Feb; 155(2):188-195. PubMed ID: 30566178
[TBL] [Abstract][Full Text] [Related]
30. Association Between Confocal Morphologic Classification and Clinical Phenotypes of Multiple Primary and Familial Melanomas.
Grazziotin TC; Alarcon I; Bonamigo RR; Carrera C; Potrony M; Aguilera P; Puig-Butillé JA; Brito J; Badenas C; Alós L; Malvehy J; Puig S
JAMA Dermatol; 2016 Oct; 152(10):1099-1105. PubMed ID: 27579522
[TBL] [Abstract][Full Text] [Related]
31. Prostate Cancer Incidence and Mortality in Relationship to Family History of Prostate Cancer; Findings From The PLCO Trial.
Abdel-Rahman O
Clin Genitourin Cancer; 2019 Aug; 17(4):e837-e844. PubMed ID: 31213414
[TBL] [Abstract][Full Text] [Related]
32. Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma.
Abdel-Rahman MH; Pilarski R; Ezzat S; Sexton J; Davidorf FH
Fam Cancer; 2010 Sep; 9(3):431-8. PubMed ID: 20157784
[TBL] [Abstract][Full Text] [Related]
33. Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus.
Pan Y; Adler NR; Wolfe R; McLean CA; Kelly JW
Med J Aust; 2017 Oct; 207(8):333-338. PubMed ID: 29020904
[TBL] [Abstract][Full Text] [Related]
34. Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases.
Helgadottir H; Höiom V; Tuominen R; Nielsen K; Jönsson G; Olsson H; Hansson J
J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27287845
[TBL] [Abstract][Full Text] [Related]
35. History of keratinocyte carcinoma and survival after a second primary malignancy: the Moffitt Cancer Center patient experience.
Amorrortu RP; Zhao Y; Stewart S; Ghia KM; Williams VL; Sondak VK; Tsai KY; Pinilla J; Chavez J; Rollison DE
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3607-3621. PubMed ID: 35962814
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with suspected nonmelanoma skin cancers, dysplastic nevus, and cutaneous melanoma among first-time SpotMe screening program participants during 2009-2010.
Beaulieu D; Tsao H; Michaud DS; Okhovat JP; Halpern AC; Geller AC
J Am Acad Dermatol; 2023 Jan; 88(1):60-70. PubMed ID: 30543833
[TBL] [Abstract][Full Text] [Related]
37. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer incidence and survival in relation to prostate cancer as second cancer in relatives.
Zheng G; Sundquist J; Sundquist K; Ji J
Cancer Med; 2022 May; 11(10):2117-2124. PubMed ID: 35312170
[TBL] [Abstract][Full Text] [Related]
39. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
